Virus Like Particles (VLP) as multivalent vaccine candidate against Chikungunya, Japanese Encephalitis, Yellow Fever and Zika Virus
出版年份 2020 全文链接
标题
Virus Like Particles (VLP) as multivalent vaccine candidate against Chikungunya, Japanese Encephalitis, Yellow Fever and Zika Virus
作者
关键词
-
出版物
Scientific Reports
Volume 10, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2020-03-04
DOI
10.1038/s41598-020-61103-1
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Virus-Like Particle Systems for Vaccine Development Against Viruses in the Flaviviridae Family
- (2019) Wong et al. Vaccines
- Capsid containing virus like particle vaccine against Zika virus made from a stable cell line
- (2019) Himanshu Garg et al. VACCINE
- Development of Virus-Like-Particle Vaccine and Reporter Assay for Zika Virus
- (2017) Himanshu Garg et al. JOURNAL OF VIROLOGY
- Major findings and recent advances in virus–like particle (VLP)-based vaccines
- (2017) Mona O. Mohsen et al. SEMINARS IN IMMUNOLOGY
- Historical Perspectives on Flavivirus Research
- (2017) Michael Holbrook Viruses-Basel
- Epidemiology of Chikungunya in the Americas
- (2016) Sergio Yactayo et al. JOURNAL OF INFECTIOUS DISEASES
- Zika Virus: New Clinical Syndromes and Its Emergence in the Western Hemisphere
- (2016) Helen M. Lazear et al. JOURNAL OF VIROLOGY
- Encephalitic Arboviruses: Emergence, Clinical Presentation, and Neuropathogenesis
- (2016) Hamid Salimi et al. Neurotherapeutics
- Estimation of parameters related to vaccine efficacy and dengue transmission from two large phase III studies
- (2016) Laurent Coudeville et al. VACCINE
- Diagnosis of arboviral infections – A quagmire of cross reactions and complexities
- (2016) Remi N. Charrel Travel Medicine and Infectious Disease
- The Long-Term Safety, Public Health Impact, and Cost-Effectiveness of Routine Vaccination with a Recombinant, Live-Attenuated Dengue Vaccine (Dengvaxia): A Model Comparison Study
- (2016) Stefan Flasche et al. PLOS MEDICINE
- Climate Change and the Arboviruses: Lessons from the Evolution of the Dengue and Yellow Fever Viruses
- (2016) Walter J. Tabachnick Annual Review of Virology
- From the monovalent to the nine-valent HPV vaccine
- (2015) S. Pils et al. CLINICAL MICROBIOLOGY AND INFECTION
- Current status and future prospects of yellow fever vaccines
- (2015) Andrew S Beck et al. Expert Review of Vaccines
- A 9-Valent HPV Vaccine in Women
- (2015) NEW ENGLAND JOURNAL OF MEDICINE
- A 9-Valent HPV Vaccine against Infection and Intraepithelial Neoplasia in Women
- (2015) Elmar A. Joura et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Randomized, Double-Blind, Phase III Study of the Immunogenicity and Safety of a 9-Valent Human Papillomavirus L1 Virus-Like Particle Vaccine (V503) Versus Gardasil® in 9–15-Year-Old Girls
- (2015) Timo Vesikari et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- Identification of conserved motifs in the Westnile virus envelope essential for particle secretion
- (2013) Himanshu Garg et al. BMC MICROBIOLOGY
- Virus-like particles for the prevention of human papillomavirus-associated malignancies
- (2013) Joshua W Wang et al. Expert Review of Vaccines
- Urbanization and geographic expansion of zoonotic arboviral diseases: mechanisms and potential strategies for prevention
- (2013) Scott C. Weaver TRENDS IN MICROBIOLOGY
- Japanese encephalitis
- (2013) Sang-Im Yun et al. Human Vaccines & Immunotherapeutics
- Flavivirus-induced antibody cross-reactivity
- (2011) K. L. Mansfield et al. JOURNAL OF GENERAL VIROLOGY
- A virus-like particle vaccine for epidemic Chikungunya virus protects nonhuman primates against infection
- (2010) Wataru Akahata et al. NATURE MEDICINE
- Present and future arboviral threats
- (2009) Scott C. Weaver et al. ANTIVIRAL RESEARCH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now